| LDR | | 05036cmm u2200733 i 4500 |
| 001 | | 000000327329 |
| 003 | | OCoLC |
| 005 | | 20240307135504 |
| 006 | | m d |
| 007 | | cr ||||||||||| |
| 008 | | 221126s2022 dcua ob 100 0 eng |
| 016 | 7 |
▼a 9918538122806676
▼2 DNLM |
| 019 | |
▼a 1351464741 |
| 020 | |
▼a 9780309686433
▼q electronic book |
| 020 | |
▼a 0309686431
▼q electronic book |
| 020 | |
▼a 9780309686457
▼q (electronic bk.) |
| 020 | |
▼a 0309686458
▼q (electronic bk.) |
| 020 | |
▼z 9780309686426 |
| 020 | |
▼z 0309686423 |
| 035 | |
▼a 3480783
▼b (N$T) |
| 035 | |
▼a (OCoLC)1351748469
▼z (OCoLC)1351464741 |
| 040 | |
▼a NLM
▼b eng
▼e rda
▼e pn
▼c NLM
▼d YDX
▼d CUS
▼d YDXIT
▼d UKAHL
▼d EBLCP
▼d OCLCO
▼d N$T
▼d 248032 |
| 042 | |
▼a pcc |
| 049 | |
▼a MAIN |
| 050 | 4 |
▼a RC307
▼b .I55 2022 |
| 060 | 00 |
▼a WF 200 |
| 082 | 04 |
▼a 616.995
▼2 23/eng/20230117 |
| 082 | 04 |
▼a 616.995
▼q OCoLC
▼2 23/eng/20230203 |
| 100 | 1 |
▼a Biffl, Claire,
▼e rapporteur. |
| 245 | 10 |
▼a Innovations for tackling tuberculosis in the time of COVID-19 :
▼b proceedings of a workshop /
▼c Claire Biffl, Julie Liao, and Anna Nicholson, rapporteurs ; Forum on Microbial Threats, Board on Global Health, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine. |
| 264 | 1 |
▼a Washington, DC :
▼b The National Academies Press,
▼c [2022] |
| 300 | |
▼a 1 online resource (1 PDF file (xx, 174 pages)) :
▼b illustrations (some colored) |
| 336 | |
▼a text
▼b txt
▼2 rdacontent |
| 337 | |
▼a computer
▼b c
▼2 rdamedia |
| 338 | |
▼a online resource
▼b cr
▼2 rdacarrier |
| 504 | |
▼a Includes bibliographical references. |
| 505 | 0 |
▼a 1. Introduction -- 2. Current Tools and Challenges -- 3. Detection -- 4. Vaccines and Therapeutics -- 5. Financing, Ambition, and Preparedness -- Appendix A: References -- Appendix B: Workshop Statement of Task -- Appendix C: Workshop Agenda. |
| 520 | 3 |
▼a Despite being preventable and curable since the middle of the twentieth century, tuberculosis (TB) has long persisted as the world's deadliest infectious disease, with the communities most devastated by TB among the poorest and most vulnerable in the world. Only about half of people with TB receive successful treatment each year. As the global threat of antimicrobial resistance continues to escalate, so do cases of drug-resistant TB, or TB that is resistant to various antibiotics that constitute standard treatment regimens. In response, the National Academies of Sciences, Engineering, and Medicine's Forum on Microbial Threats held a two-part virtual workshop on July 22 and September 14-16, 2021 titled Innovations for Tackling Tuberculosis in the Time of COVID-19. The aims of the workshop were to evaluate the current status of TB elimination, assess the effects of the COVID-19 pandemic on the global fight against TB, and examine technical and strategic innovations that could be leveraged to meet the United Nations High-Level Meeting on Tuberculosis targets in 2022 and The World Health Organization's END TB Strategy targets by 2030. This publication summarizes the presentations and discussions of the workshop. |
| 536 | |
▼a This activity was supported by a contract between the National Academy of Sciences and the U.S. Agency for International Development (10004113). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. |
| 588 | |
▼a Description based on online resource; title from digital title page (viewed on January 17, 2023). |
| 590 | |
▼a Added to collection customer.56279.3 |
| 650 | 0 |
▼a Tuberculosis
▼x History
▼y 21st century
▼v Congresses. |
| 650 | 0 |
▼a COVID-19 (Disease)
▼v Congresses. |
| 650 | 12 |
▼a Tuberculosis, Multidrug-Resistant
▼x prevention & control |
| 650 | 12 |
▼a Tuberculosis, Multidrug-Resistant
▼x history |
| 650 | 22 |
▼a COVID-19
▼x complications |
| 650 | 22 |
▼a Disease Eradication |
| 650 | 22 |
▼a Therapies, Investigational |
| 650 | 6 |
▼a Tuberculose
▼x Histoire
▼y 21e sie?cle
▼v Congre?s. |
| 650 | 6 |
▼a COVID-19
▼v Congre?s. |
| 650 | 7 |
▼a COVID-19 (Disease)
▼x Treatment
▼2 fast |
| 655 | 2 |
▼a Congress |
| 655 | 7 |
▼a proceedings (reports)
▼2 aat |
| 655 | 7 |
▼a Conference papers and proceedings
▼2 fast |
| 655 | 7 |
▼a Conference papers and proceedings.
▼2 lcgft |
| 655 | 7 |
▼a Actes de congre?s.
▼2 rvmgf |
| 700 | 1 |
▼a Liao, Julie,
▼e rapporteur. |
| 700 | 1 |
▼a Nicholson, Anna,
▼e rapporteur. |
| 710 | 2 |
▼a National Academies of Sciences, Engineering, and Medicine (U.S.).
▼b Forum on Microbial Threats,
▼e issuing body. |
| 711 | 2 |
▼a Innovations for Tackling Tuberculosis in the Time of COVID-19 (Workshop)
▼d (2021 :
▼c Online) |
| 776 | 08 |
▼i Print version:
▼a Biffl, Claire.
▼t Innovations for tackling tuberculosis in the time of COVID-19.
▼d Washington, DC : The National Academies Press, [2022]
▼z 9780309686426
▼w (OCoLC)1306524286 |
| 856 | 40 |
▼3 EBSCOhost
▼u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3480783 |
| 938 | |
▼a EBSCOhost
▼b EBSC
▼n 3480783 |
| 990 | |
▼a 관리자 |
| 994 | |
▼a 92
▼b N$T |